Delivery Order SPE2DB22D3301-SPE2DB25FX8UN
Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Visipaque 320 mg/ml, a pharmaceutical product, with a ceiling value of $26,715.17 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This is a delivery order worth $1,383.12 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML pharmaceutical products. The contract has a final completion date of September 24, 2024 and uses a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a ceiling value of $1,599.88. The contract type is a Delivery Order with a Firm Fixed Price pricing model. The ultimate completion date is July 16, 2025. This contract is not set aside and...
- This is a $13,839.57 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance through January 31, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,455.60, is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has an ultimate completion date of July 8, 2024 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, with a ceiling value of $1,650.56. It is a firm fixed price delivery order contract, with a period of performance ending on June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $4,169.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Visipaque 320 mg/ml infusion bottles, a specialty pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 17, 2023. The award was made on November 16, 2023. There is no set-aside designation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product, with a ceiling value of $4,219.10 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.56, is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...